EGFR and non-small cell lung carcinoma: In another retrospective study, Afatinib combined with stereotactic radiosurgery (SRS) can significantly improve the OS of patients with EGFR mutant NSCLC (lung mol GPA ≥ 3) with brain metastasis (29).